Antipsychotic
The Mental Health Pharmacogenetic Test is a modern diagnostic tool to help determine drug therapy. It examines the individual interaction between a patient's genome and a drug. The test results are a factor in optimizing the dose or in choosing an alternative drug to avoid side effects and to optimize the efficacy of the prescribed therapy. The Mental Health Pharmacogenetic Test is an additional toll to the standard approach when prescribing therapy, which could eliminate the long path of trial-and-error and the unexpected side effects of drug selection and dosing.
Results for patients with the same diagnosis treated in the same way can be different. The same drug can be very effective or ineffective, may have no side effects, or may have many as for each person the genome and the combination of enzymes it produces is unique.
Diagnostic Range: Typical and atypical antipsychotic
Diagnostic Method: Sanger sequencing/ RFLP
Research Material: Venous blood
Results within: 10 business days
Fee: BGN 1,030
Clinical application
Determining the appropriate dose for upcoming therapy
Antidepressants
The Mental Health Pharmacogenetic Test is a modern diagnostic tool to help determine drug therapy. It examines the individual interaction between a patient's genome and a drug. The test results are a factor in optimizing the dose or in choosing an alternative drug to avoid side effects and to optimize the efficacy of the prescribed therapy. The Mental Health Pharmacogenetic Test is an additional toll to the standard approach when prescribing therapy, which could eliminate the long path of trial-and-error and the unexpected side effects of drug selection and dosing.
Results for patients with the same diagnosis treated in the same way can be different. The same drug can be very effective or ineffective, may have no side effects, or may have many as for each person the genome and the combination of enzymes it produces is unique.
Diagnostic Range: Antidepressants - SSRI, SNRI, tricyclic, tetracyclic and others
Diagnostic Method: Sanger sequencing/ RFLP
Research Material: Venous blood
Results within: 10 business days
Fee: BGN 790
Clinical application
Determining the appropriate dose for upcoming therapy
Microbiome MINI
Microbiome MINI involves molecular genetic diagnosis to identify all bacterial species inhabiting the intestinal tract. It covers over 250 parameters, used to determine biodiversity, condition and permeability of the intestinal mucosa, the formation of functional groups (equol, butyrate, histamine, hydrogen sulfide), parasites presence. Valuable information about a person's health and lifestyle can be obtained depending on the microbiome condition.
Diagnostic Range: Feces condition; Biodiversity; Distribution of bacterial genera; Enterotype; Dysbiosis index; Most important bacterial genera and species: Bacteriodetes, Firmicutes, Actinobacteria, Proteobacteria (pathogenic or potentially pathogenic), Verrucomicrobia, Clostridia, Immunologically effective species, Yeast / Fungi and other forming functional groups (equol, butyrate, histamine, hydrogen sulfide).
Diagnostic Method: New generation sequencing and DNA quantification
Research Material: Feces
Results within: 15-20 business days
Fee: BGN 378
Clinical application
Metabolic disorders; Intestinal inflammation (Crohn's disease); Intestinal tumors; Autism; Alzheimer's; Arthritis; Obesity
Mental Health (Main Panel)
The Mental Health Pharmacogenetic Test is a modern diagnostic tool to help determine drug therapy. It examines the individual interaction between a patient's genome and a drug. The test results are a factor in optimizing the dose or in choosing an alternative drug to avoid side effects and to optimize the efficacy of the prescribed therapy. The Mental Health Pharmacogenetic Test is an additional toll to the standard approach when prescribing therapy, which could eliminate the long path of trial-and-error and the unexpected side effects of drug selection and dosing.
Results for patients with the same diagnosis treated in the same way can be different. The same drug can be very effective or ineffective, may have no side effects, or may have many as for each person the genome and the combination of enzymes it produces is unique.
Diagnostic Range: Antidepressants - SSRI, SNRI, tricyclic, tetracyclic and others; Antixiolytics; Typical and atypical antipsychotic; Mood stabilizers
Diagnostic Method: Sanger sequencing/ RFLP
Research Material: Venous Blood
Results within: 10 business days
Fee: BGN 1,170
Clinical application
Determining the appropriate dose for upcoming therapy
Metabolism of Dopamine, Serotonin, and Folate
The Mental Health Pharmacogenetic Test is a modern diagnostic tool to help determine drug therapy. It examines the individual interaction between a patient's genome and a drug. The test results are a factor in optimizing the dose or in choosing an alternative drug to avoid side effects and to optimize the efficacy of the prescribed therapy. The Mental Health Pharmacogenetic Test is an additional toll to the standard approach when prescribing therapy, which could eliminate the long path of trial-and-error and the unexpected side effects of drug selection and dosing.
Results for patients with the same diagnosis treated in the same way can be different. The same drug can be very effective or ineffective, may have no side effects, or may have many as for each person the genome and the combination of enzymes it produces is unique.
Diagnostic Range: Cerebral neurotransmitter - metabolism of dopamine, serotonin and folate; Antidepressants - SSRI, SNRI, tricyclic, tetracyclic and others; Antixiolytics; Typical and atypical antipsychotic; Mood stabilizers
Diagnostic Method: Sanger sequencing/ RFLP
Research Material: Venous blood
Results within: 10 business days
Fee: BGN 410
Clinical application
Determining the appropriate dose for upcoming therapy
Mental Health (Full Panel)
The Mental Health Pharmacogenetic Test is a modern diagnostic tool to help determine drug therapy. It examines the individual interaction between a patient's genome and a drug. The test results are a factor in optimizing the dose or in choosing an alternative drug to avoid side effects and to optimize the efficacy of the prescribed therapy. The Mental Health Pharmacogenetic Test is an additional toll to the standard approach when prescribing therapy, which could eliminate the long path of trial-and-error and the unexpected side effects of drug selection and dosing.
Results for patients with the same diagnosis treated in the same way can be different. The same drug can be very effective or ineffective, may have no side effects, or may have many as for each person the genome and the combination of enzymes it produces is unique.
Mental health (full panel) includes all the tests in Mental health (main panel) + Brain neurotransmission - metabolism of dopamine, serotonin, and folate.
Diagnostic range: Cerebral neurotransmitter - metabolism of dopamine, serotonin and folate; Antidepressants - SSRI, SNRI, tricyclic, tetracyclic and others; Antixiolytics; Typical and atypical antipsychotic; Mood stabilizers
Diagnostic Method: Sanger sequencing/ RFLP
Research Material: Venous blood
Results within: 10 business days
Fee: BGN 1,320
Clinical application
Determining the appropriate dose for upcoming therapy
Mood Stabilizers
The Mental Health Pharmacogenetic Test is a modern diagnostic tool to help determine drug therapy. It examines the individual interaction between a patient's genome and a drug. The test results are a factor in optimizing the dose or in choosing an alternative drug to avoid side effects and to optimize the efficacy of the prescribed therapy. The Mental Health Pharmacogenetic Test is an additional toll to the standard approach when prescribing therapy, which could eliminate the long path of trial-and-error and the unexpected side effects of drug selection and dosing.
Results for patients with the same diagnosis treated in the same way can be different. The same drug can be very effective or ineffective, may have no side effects, or may have many as for each person the genome and the combination of enzymes it produces is unique.
Diagnostic Range: Antixiolytics; Mood stabilizers
Diagnostic Method: Sanger sequencing/ RFLP
Research Material: Venous blood
Results within: 10 business days
Fee: BGN 850
Clinical application
Determining the appropriate dose for upcoming therapy
Microbiome MIDI
The Microbiome MIDI genetic panel is an extension of Microbiome MINI panel and additional types of parasites (Giardia lamblia, Entamoeba histolytica, etc.) are included.
Diagnostic Range: Feces condition; Biodiversity; Distribution of bacterial genera; Enterotype; Dysbiosis index; Most important bacterial genera and species: Bacteriodetes, Firmicutes, Actinobacteria, Proteobacteria (pathogenic or potentially pathogenic), Verrucomicrobia, Clostridia, Immunologically effective species, Yeast / Fungi and other forming functional groups (equol, butyrate, histamine, hydrogen sulfide); Additional types of parasites.
Diagnostic Method: New generation sequencing and DNA quantification
Research Material: Feces
Results within: 15-20 business days
Fee: BGN 459
Clinical application
Metabolic disorders; Intestinal inflammation (Crohn's disease); Intestinal tumors; Autism; Alzheimer's; Arthritis; Obesity
Microbiome MAXI
The Microbiome MAXI genetic panel is an extension of Microbiome MIDI panel and additional species of the genera Actinobacteria and Clostridia; Hydrogen sulfide producing bacteria and Oxalate - degrading bacteria are included.
Diagnostic Range: Feces condition; Biodiversity; Distribution of bacterial genera; Enterotype; Dysbiosis index; Most important bacterial genera and species: Bacteriodetes, Firmicutes, Actinobacteria, Proteobacteria (pathogenic or potentially pathogenic), Verrucomicrobia, Clostridia, Immunologically effective species, Yeast / Fungi, and other forming functional groups (equol, butyrate, histamine, hydrogen sulfide); Additional types of parasites; Additional species of Actinobacteria, Clostridia; Additional species of hydrogen sulfide-producing bacteria; Oxalate - degrading bacteria
Diagnostic Method: New generation sequencing and DNA quantification
Research Material: Feces
Results within: 15-20 business days
Fee: BGN 507
Clinical application
Metabolic disorders; Intestinal inflammation (Crohn's disease); Intestinal tumors; Autism; Alzheimer's; Arthritis; Obesity
Vitamins
Vitamins play a key role in the proper performance of basic functions of the human body such as metabolism, immune defense, activity of the central and peripheral nervous systems, digestion, movement etc. Most vitamins are not synthesized in the human body but are taken with food as precursors of their active forms. Therefore, their proper absorption, transformation, use, and decomposition is important for maintaining the so-called vitamin balance.
The Vitamins Genetics Panel includes an analysis of genetic variants associated with predisposition to vitamin A, B, D, and K deficiencies. The results contain interpretation, clinical significance of proven variants, and recommendations that assist practitioners in making therapeutic decisions. Each patient receives guidelines for changing their diet, as well as for taking specific vitamins and minerals.
Diagnostic Range: Absorption of vitamins A, B2, B6, B9 (folic acid), B12, D and K.
Diagnostic Method: Sanger sequencing/ RFLP
Research Material: 3-6 ml venous blood / 2 ml peripheral blood
Results within: 10 business days
Fee: BGN 710
Clinical application
Eating disorders; Metabolic disorders
Vitamin B6
Vitamin B6 is an important factor in the formation of the red blood cells, the developing of nervous tissue, the detoxification processes, the DNA synthesis, the cell energy balance and the immune protection. It is also a key factor in the methylation processes that regulate the "unlocking" or "locking" of our genes. Methylation disorders can lead to elevated homocysteine levels, which are associated with a large number of diseases.
Vitamin B6 Genetic Panel includes analysis of genetic variants associated with faster degradation of vitamin B6 and systemically low bioavailability of its active form, called Pyridoxal-5-phosphate. The results contain interpretation, clinical significance of identified variants and recommendations to assist specialists in making therapeutic decisions.
Diagnostic Range: Genetic variants associated with deficiency and faster degradation of Vitamin B6
Diagnostic Method: Sanger sequencing
Research Material: 3-6 ml venous blood / 2 ml peripheral blood
Results within: 10 business days
Fee: BGN 150
Clinical application
Metabolic disorders; Eating disorders
Vitamin B12
Vitamin B12 is supplied only with food. It is a key factor in to the functioning of vital body processes, including the formation of red blood cells, DNA synthesis, normal nervous system function, digestion. If Vitamin B12 deficiency is not managed in time, it can lead to anemia, a number of gastrointestinal, neurological, oncological, and other diseases.
Vitamin B12 Genetic Panel includes analysis of genetic variants associated with disorders in the absorption of the vitamin in the small intestine, reduced transport to the liver and faster depletion of its active form.
The results contain interpretation, clinical significance of identified variants and recommendations to assist specialists in making therapeutic decisions.
Diagnostic Range: Absorption, transport and use of vitamin B12 in the body.
Diagnostic Method: Sanger sequencing/ RFLP
Research Material: 3-6 ml venous blood / 2 ml peripheral blood
Results within: 10 business days
Fee: BGN 280
Clinical application
Neurology; Hematology; Endocrinology; Gastroenterology; Psychiatry Anemia
Histamine Intolerance
A wide range of foods are naturally rich in histamine or release high levels of histamine during storage. Diamine oxidase (DAO) is an intestinal enzyme that normally destroys histamine contained in food. Therefore, even after consuming foods rich in histamine, no symptoms are observed. In carriers of genetic variants, DAO deficiency is observed, and undigested histamine is unnecessarily absorbed, exhibiting various symptoms.
Gastrointestinal symptoms: diarrhea, irritable bowel syndrome (IBS), chronic constipation, gas, stomach pain, vomiting.
Symptoms affecting the head and face: redness of the face and / or chest (a very common symptom), migraine-like headache, Quincke's edema (swelling that occurs mainly around the eyes and lips, sometimes in the throat).
Respiratory problems: asthma, stuffy nose and watery eyes.
Skin complaints: rash, eczema, urticaria, acne.
In women: dysmenorrhea. The symptoms of HIT disappear during pregnancy and return after birth.
Other symptoms: wheezing, sleep disorders, arrhythmia, mood swings - from fatigue to irritability and aggression.
Diagnostic Range: DAO; HNMT
Diagnostic Method: Sanger sequencing
Research Material: 3-6 ml venous blood / 2 ml peripheral blood
Results within: 10 business days
Fee: BGN 200
Clinical application
Histamine intolerance